172 results on '"Ceballos D"'
Search Results
2. P180 Novel biomarkers associated with inflammatory bowel disease
3. P1023 Variability in Mesalazine Management for Ulcerative Proctitis Include Doses, Route of Administration and Use of Fecal Calprotectin: Insights from Clinical Practice Across Spain Beyond Clinical Guidelines
4. DOP74 Short and long-term effectiveness and safety of ustekinumab in Ulcerative Colitis in real life: the ULISES study
5. P010 Faecal microbiota composition by shotgun metagenomic sequencing approach in a newly diagnosed cohort of inflammatory bowel disease patients: results from the IBDomics project
6. Prevalence of information stored in arrays of magnetic nanowires against external fields
7. P036 Analysis of intestinal tissue from newly diagnosed patients with inflammatory bowel disease reveals distinct proteomic profiles
8. P654 Controversies in the management of anti-TNF therapy in Crohn’s disease patients. A Delphi consensus
9. P106 Identification of urine and serum diagnostic biomarkers of inflammatory bowel disease using a proteomic approach
10. P049 Proteomic characterization of serum extracellular vesicles from newly diagnosed patients with inflammatory bowel disease
11. P618 Rapidity of onset of response to adalimumab in luminal Crohnʼs disease. Data from RAPIDA trial
12. P423 Early improvement in quality of life in patients with luminal Crohnʼs disease treated with adalimumab. Data from RAPIDA trial
13. P327 Evolution after a “de-intensification” strategy with anti-TNF therapy in patients with inflammatory bowel disease in clinical remission: multicenter study
14. DOP063 Serial tuberculin skin test improves the detection of latent tuberculosis infection in inflammatory bowel disease patients
15. P018 Proteomic profile of serum and urine in newly diagnosed patients with Inflammatory Bowel Disease: new approach for biomarker discovery
16. Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study
17. DOP19 Urinary metabolome in newly diagnosed treatment-naïve Crohn’s Disease patients: Results from the IBDomics study
18. Abstract No. 475 Between a Rock and a hard place: transgluteal versus transrectal drainage catheter pain scores
19. Role of metallothioneins in peripheral nerve function and regeneration
20. Engineering an artificial nerve graft for the repair of severe nerve injuries
21. Artificial nerve graft for the repair of peripheral nerve injuries
22. Abstract No. 523 Biopsy-gauge size, patient, and lesional factors affecting iatrogenic pneumothorax rates for lung biopsies
23. P744 Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): Results from the nationwide EpidemIBD study of GETECCU
24. Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial
25. Efficacy and safety of short-term adalimumab treatment in patients with active Crohnʼs disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial
26. Gonadal maturation in captivity and hormone-induced spawning of the Pacific red snapper Lutjanus peru
27. Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease
28. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
29. Weighted-selective aggregated majority-OWA operator and its application in linguistic group decision making
30. Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study
31. P339 Crohn’s disease and self-monitoring through a mobile App: The Medicrohn study
32. P623 Quality of life as predictor of biological levels decay in inflammatory bowel diseases
33. P779 Clinical outcome with biological therapy in ulcerative colitis: Real-world clinical setting from a multi-centre observational study
34. Owa-based aggregation operations in multi-expert mcdm model
35. Estudio y clasificación de los riesgos legales de la innovación financiera
36. Immunohistochemical analysis of cutaneous innervation as a tool in the diagnosis of small-fibre neuropathies
37. Morphological and functional evaluation of peripheral nerve fibers regenerated through polyimide sieve electrodes over long-term implantation
38. Estudio y clasificación de los riesgos legales de la innovación financiera (Study and classification of legal risks in finance innovation)
39. P563 Clinical response and quality of life in patients with Crohn's disease treated with adalimumab in routine clinical practice
40. P564 Clinical response, quality of life and work activity in patients with Crohn's disease treated with adalimumab in routine clinical practice
41. P573 Changes in resource utilisation in patients with Crohn's disease treated with adalimumab in routine clinical practice
42. Peripheral nerve regeneration through bioresorbable and durable nerve guides
43. Stability of soliplasmon excitations at metal/dielectric interfaces
44. Role of metallothioneins in peripheral nerve function and regeneration
45. RIESGO DE DESARROLLAR UNA ENFERMEDAD DE CROHN GRAVE TRAS EL DIAGNÓSTICO: VALIDACIÓN EN POBLACIÓN ESPAÑOLA DE CRITERIOS CLÍNICOS PREDICTIVOS PROPUESTOS
46. Soliplasmon excitations at metal/dielectric/Kerr structures
47. Long-Term Results of Adalimumab Treatment in Subjects with Moderately to Severely Active Fistulizing Crohnʼs Disease Who Have Failed Response or Showed Intolerance to Infliximab
48. Caracterización de Lactantes con infección del Tracto Urinario. 2009-2010. Hospital Regional de Antofagasta.
49. Uso de rutas químicas para sintetizar ZrO2 tetragonal.
50. Effects of FK506 on nerve regeneration and reinnervation after graft or tube repair of long nerve gaps.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.